BioXtal is a company that has been providing R&D services to the pharmaceutical industry since its inception in 1998. BioXtal has continually expanded its offerings in the field of structural biology. Their services include protein structure analysis, production of proteins, membrane extracts, and Nanobodies. Notably, in January 2024, BioXtal launched a partnership with APHP to introduce the SNPXplex, a reagent for identity Monitoring. This reagent enhances the security of NGS and genomic analyses for personalized medicine. For a deeper understanding of protein structures, BioXtal’s cutting-edge techniques can help you unravel the mysteries of protein function and design new drugs. 

Learn More: 

Website: https://www.bioxtal.com/